Barron's - USA (2020-12-07)

(Antfer) #1

December 7, 2020 BARRON’S M11


Research Reports


HowAnalystsSizeUpCompanies


Thesereports,excerptedandeditedbyBarron’s,wereissuedrecentlybyinvestmentand


research firms. The reports are a sampling of analysts’ thinking; they should not be


consideredtheviewsorrecommendationsofBarron’s.Someofthereports’issuershave


provided, or hope to provide, investment-banking or other services to the companies


being analyzed.


To be considered for this section, material


should be sent [email protected].


Toll Brothers•TOL-NYSE


Outperform•Price $47.56 on Nov. 30


by Wedbush


We reiterate our Outperform rating on Toll


Brothers ahead of the fourth-quarter


(October) earnings-per-share release that


is scheduled for after the market close on


Dec. 7. We are ahead of the Thomson con-


sensus estimates on orders and EPS, as we


anticipate that demand for larger, flexible


floor plans may be higher than consensus


assumptions.


On the call, we will look for commentary


around pricing power as well as the level of


demand/traffic prior to the normal holiday


slowdown. We will also be interested in


Toll’s plans for the spring season and an


update on Toll’s fiscal-year 2021 community


growth outlook, which currently stands at


10%. Price target: $57.


Zoom Video Communications



  • ZM-Nasdaq


Buy•Price $478.36 on Dec. 1


by Needham


Zoom’s third-quarter print was strong,


with revenue up 367% year over year, 12%


ahead of consensus, and fiscal-2021 guid-


ance raised by 8%. We estimate that Zoom


added 2.5 million net new paying subscrip-


tions in the third quarter, following the


nearly doubling of subs in the second quar-


ter. Acknowledging that Zoom shares will


likely continue to be subject to volatility on


potential rotation away from work-from-


home names and/or concerns regarding


tough comps looming in the second quarter


of fiscal 2022 and beyond, we think that an


enduring shift toward remote work and


Zoom’s rapidly growing installed base into


which it can cross-sell phones, rooms, and


future products afford it the opportunity to


double revenue again in the next three to


four years.


Price target: $540.


Wells Fargo•WFC-NYSE


Sector Perform•Price $28.46 on Nov. 30


by RBC Capital Markets


At present prices, we believe that the


stock fully discounts the company’s regula-


tory and structural problems. As a result,


we are raising our rating to Sector Per-


form from Underperform. The company’s


stock is down 47% year to date, below the


KBW Nasdaq Bank Index’s performance of


minus 18%.


Management emphasized on the third-


quarter earnings call its ongoing commit-


ment to running the company more effec-


tively and efficiently. Additionally, the


company indicated that it would lay out its


restructuring plans on its fourth-quarter


earnings call in January....Over recent


years, Wells Fargo has sold selected busi-


nesses that were not core to its commercial


banking franchise, e.g., Wells Fargo Insur-


ance Services USA and its Institutional


Retirement Trust business. We anticipate,


as the new executive team looks to turn the


company around, that potential business


divestitures should not be ruled out, e.g.,


its asset-management business.


Price target: $31.


Kohl’s•KSS-NYSE


Buy•Price $36.52 on Dec. 1


by Guggenheim


Kohl’s announced a long-term strategic


partnership with Sephora to bring a new


elevated Beauty experience to Kohl’s, in-


cluding 200 Sephora at Kohl’s locations


open in fall 2021 (and 850-plus by 2023)


and the launch of Sephora on Kohls.com in






We believe that this fits into Kohl’s new


strategic framework outlined in October


2020, which highlighted Beauty as a key


opportunity. Importantly, we expect Sep-


hora to drive traffic and support top-line


growth while also being operating-margin


accretive, helping Kohl’s to deliver on its


7% to 8% operating margin target. We


raise our price target to $40 from $35.


Interactive Brokers Group



  • IBKR-Nasdaq


Overweight•Price $53.98 on Dec. 1


by Piper Sandler


We are raising our fourth-quarter EPS esti-


mate due to stronger-than-anticipated trad-


ing, continued account growth, and strong


margin balance and customer equity growth.


Cleared daily average revenue trades for No-


vember were up 31% month over month to a


record, outperforming our forecast of +5.55.


The average commission of $2.45 per trade


was a slight offset, as it came in below our


previous fourth-quarter estimate of $2.49.


New accounts were 29,000, as customer eq-


uity was up 11% month over month, while


margin balances increased 4% month over


month. We are raising our fourth-quarter


EPS estimate to $0.56 from $0.54 as Interac-


tive Brokers generally outperformed our ex-


pectations for November. Price target: $60.


FLIR Systems•FLIR-Nasdaq


Buy•Price $40.02 on Dec. 3


by Canaccord Genuity


FLIR Systems announced the acquisition of


Altavian, a small military-drone manufac-


turer. FLIR...could now potentially be a


prime contractor selected for the Short


Range Reconnaissance effort, which is seek-


ing a drone for the Army capable of being


carried in a rucksack and carrying out


flights with a minimum duration of 30 min-


utes or three kilometers. Price target: $50.


INSIDER TRANSACTIONS RATIO


0


10


20


30


40


50


60


D J F M A M J J A S ON


Ratio of Insiders Sales to Buys. Readings under 12:1 are Bullish. Those over 20:1 are Bearish.


The total top20 sales and buys are 664, 296 ,458 and 17, 591 ,184 respectively; Source: Thomson Reuters


Bearish


Bullish


Ratio = 38


INSIDER TRANSACTIONS: Recent Filings


Purchases


$Val
Company/Symbol Insiders Shares (000's)

EspeyMfgAndElectronicsESP 2 600,000 10,974
AmericanAssetsTrustAAT 1 50,089 1,452

GenesisParkAcquisitionGNPKU 3 145,000 1,450
MaravaiLifesciencesMRVI 2 50,000 1,348

MerrimackPharmaceuticalsMACK 2 138,175 504

KeurigDrPepperKDP 1 7,500 227
FlotekIndustriesFTK 2 89,231 184
ReproMedSystemsKRMD 3 32,827 148

CenturyBancorpCNBKA 3 1,688 131

StateAutoFinancialSTFC 1 8,550 129

PcbBancorpPCB 1 11,686 127

AmarinAMRN 1 25,000 122
FreightcarAmericaRAIL 2 50,500 114

ChiasmaCHMA 1 25,000 107

ClearsideBiomedicalCLSD 1 53,900 105

LuminexLMNX 1 4,487 101

CentralValleyCommunityBancorpCVCY 2 7,001 100
EmployersEIG 1 3,200 98
MeridianBioscienceVIVO 1 5,000 88

BankFirstBFC 1 1,200 81

Sales


$ Val
Company/Symbol Insiders Shares (000's)

SouthernCopperSCCO 1 1,293,245 73,415
CarvanaCVNA 3 290,000 68,307
PinterestPINS 1 945,000 59,002

Procter&GamblePG 1 306,567 42,096

Tiffany&CoTIF 7 306,878 40,384

FacebookFB 2 137,618 38,001

EnphaseEnergyENPH 4 259,418 36,579
TraneTechnologiesTT 2 248,115 35,937

GreenDotGDOT 1 690,000 35,856

BroadcomAVGO 1 78,125 30,484

LaredoPetroleumLPI 1 2,558,505 29,668

CelsiusCELH 2 918,108 28,903
PaloAltoNetworksPANW 2 92,000 27,081
MontroseEnvironmentalMEG 3 944,876 24,654

SquareSQ 1 100,000 20,914

ServicenowNOW 1 38,600 18,855
SlackTechnologiesWORK 5 415,000 16,527

ZillowZ 4 117,134 12,752
CrisprTherapeuticsCRSP 1 100,000 12,500

AxonEnterpriseAAXN 2 98,500 12,383

Aninsiderisanyofficer,directororownerof10%ormoreofaclassofacompany'ssecurities.Inmostcases,aninsidermustreportanytradeto
theSECwithintwobusinessdays.ThetableshighlightcompaniesthatfiledwiththeSECthroughlastWednesday.Thetablesdonotinclude
pension-planoremployeestock-optionactivity,tradesbybeneficialownersof10%ormore,tradesunder$2pershareortradesunder100
shares.The"Purchases"columnincludesonlyopen-marketandprivatepurchases;the"Sales"columnincludesonlyopen-marketandprivatesales,
andexcludestradesprecededbyoptionexerciseinthe12monthspriortothereportedevent. Source:ThomsonReuters
Free download pdf